Sustainability report

Product lifecycle, design & innovation

Edwards Lifesciences’ work to improve product lifecycle, design and innovation supports our aspirations of Transforming Patient Lives with Breakthrough Medical Technologies and Passionate Engagement that Strengthens Our Communities.


Innovating to improve quality, design and performance of products and reducing environmental impacts of Edwards’ products throughout their lifecycle.

Our aspirations


Transforming patient lives with breakthrough medical technologies


Passionate engagement that strengthens our communities

Material topics
Highlight story

First INSPIRIS RESILIA aortic valve implantations

The first two patients to receive the Inspiris Resilia aortic valve were successfully treated in the UK. Dr. Olaf Wendler, a consultant cardiothoracic surgeon at King’s College Hospital, who performed one of the surgeries, said, “This new device represents a huge step forward in the advancements of heart valve treatment providing surgeons and their active patients with an improved, longer lasting, treatment option. Thanks to such modern advancements, heart valve disease patients can now live longer with an improved quality of life.” The Inspiris Resilia aortic valve is the first in a new class of resilient heart valves, which incorporates advanced RESILIA tissue, leverages features of the PERIMOUNT Magna Ease valve and includes the proprietary VFit technology, designed for potential future valve-in-valve procedures.